SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549
_____________________________
FORM 8-K
CURRENT REPORT
Pursuant to Section 13 or 15(d) of the
Securities Exchange Act of 1934
Date of Report (Date of earliest event reported): July 21, 2004
ORPHAN MEDICAL, INC.
(Exact name of registrant as specified in its charter)
Delaware | 0-24760 | 41-1784594 |
(State or other jurisdiction of incorporation) | (Commission file number) | (I.R.S. employer identification number) |
Suite 250, 13911 Ridgedale Drive, Minnetonka, MN | 55305 | (952) 513-6900 |
(Address of principal executive offices) | (zip code) | (Registrant's telephone number, including area code) |
Not Applicable |
(Former name or former address, if changed since last report) |
ITEM 12. RESULTS OF
OPERATIONS AND FINANCIAL CONDITION.
On July 21, 2004, Orphan Medical issued a press release discussing second quarter 2004
results. The press release is included as Exhibit 99.1 hereto and is incorporated herein
by reference. The press release contains forward-looking statements regarding the Company
and includes a cautionary statement identifying important factors that could cause actual
results to differ materially from those anticipated.
SIGNATURES
Pursuant to the requirements of the Securities Exchange Act of 1934, the Registrant has duly caused this Report to be signed on its behalf by the undersigned hereunto duly authorized.
Date: July 22, 2004 | ORPHAN MEDICAL, INC. |
/s/ Timothy G. McGrath | |
Timothy G. McGrath Chief Financial Officer (duly authorized officer and principal financial officer) |
EXHIBIT INDEX
Exhibit | |
Number | Description |
99.1 | Press release dated July 21, 2004. |